drugset / Trial / NCT00375076

Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients

NCT00375076

Phase 3 Completed Medical University of Vienna
RandomizedParallel-groupDouble-blind

Summary

In a prospective, randomized, double-blind trial, the effects of two different dosages of LMWH (5000 anti-Xa U od sc and 10 000 anti-Xa U od sc daily) on markers of hemostatic system and thrombin generation will be investigated in non-surgical cancer patients will be investigated.

Timeline

Start
2006-06
Primary completion
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Enoxaparin sodium Other / unclassified 5000 iu Subcutaneous
Subject Enoxaparin sodium Other / unclassified 10000 iu Subcutaneous

Indications